LGND - Ligand to buy APEIRON Biologics for $100M ups 2024 revenue outlook July, 08 2024 07:17 AM Ligand Pharmaceuticals Incorporated 2024-07-08 07:17:53 ET More on Ligand Pharmaceuticals Ligand: Buy This Pharma Royalty Aggregator To Generate Growth In Your Portfolio Agenus gains after updating early-stage cancer drug data Ligand Pharmaceuticals Non-GAAP EPS of $1.20 beats by $0.37, revenue of $30.98M beats by $3.06M For further details see: Ligand to buy APEIRON Biologics for $100M, ups 2024 revenue outlook